Stock of the Day
November 3, 2021
NovoCure (NVCR)
$22.09
+$0.44 (+2.0%)
Market Cap:
$2.34B
About NovoCure
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally.
The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Recent News
Luxury hotels group Firmdale has sold 20% stake to Swedish pharma tycoon
(msn.com)